Kate Merton

Kate Merton is Head of Johnson & Johnson Innovation, JLABS @ NYC. Kate has over 15 years of experience working across the Healthcare industry starting in R&D before moving onto roles in in Marketing, Business Development, External Alliances, Medical Affairs, Health Outcomes and most recently Disruptive Innovation. During her career Kate has been part of teams that have discovered new drugs, worked to develop and gain approval for blockbuster diabetes products and is passionate about being part of the future of healthcare where science intersects with the rapid advancements in health care technology. Kate received her undergraduate degree in Pharmacology & Toxicology from King’s College London, holds a PhD in Pharmacology & Toxicology from University of California, Irvine Medical School and received her MBA from the Fuqua School of Business at Duke University.

Johnson & Johnson Innovation / Head, JLABS @ NYC
board-of-directors